David Westenberg

David A. Westenberg, a partner in the Corporate Practice Group of WilmerHale in Boston, is author of the acclaimed book Initial Public Offerings: A Practical Guide to Going Public (Practising Law Institute, October 2009).

Recent posts

FAST Act Offers More Goodies to Emerging Growth Companies
Once again proving that you can’t judge a gift by its box, emerging growth companies (EGCs) received a pleasant, but oddly wrapped, surprise in December with the enactment of a new... Read more »
JOBS Act: Important Benefits for Startups Not on the IPO On-Ramp
The JOBS Act is probably best-known for creating an “IPO on ramp” intended to reduce the cost and complexity of going public, but the act also contains important benefits for startups... Read more »
The JOBS Act—The “IPO On-Ramp” Makes IPOs Easier
Enacted with great fanfare in early April, the JOBS Act is intended to improve access to the public capital markets for startup companies. The cornerstone of the act is the creation... Read more »
From Main Street to Wall Street—10 Things a Startup Should Do to Groom Itself for an Eventual IPO
You’ve got the vision, the core team, and even a little money. You’re prepared to devote enormous time and energy to your new startup. You’re unsure what the future will bring... Read more »
Ready, Set, Go Public—The 10 Things You Need to Do Now
The IPO market is open for business. The IPO market window has slammed shut. Which is it? Unless your IPO is pricing in the next week or two, it doesn’t matter.... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Investors Bet on Next-Gen Telehealth as COVID-19 Fuels Adoption

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Organovo Future Unclear After Shareholders Reject Tarveda Merger

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic

Xcelerating Life Sciences Boston (interactive online event)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

David Westenberg

Recent posts

FAST Act Offers More Goodies to Emerging Growth Companies

JOBS Act: Important Benefits for Startups Not on the IPO On-Ramp

The JOBS Act—The “IPO On-Ramp” Makes IPOs Easier

From Main Street to Wall Street—10 Things a Startup Should Do to Groom Itself for an Eventual IPO

Ready, Set, Go Public—The 10 Things You Need to Do Now

Underwriters and Partners

How Big Is the US Market for Medical Devices & Technologies?

How to Approach Life Sciences Fundraising

2019 Biopharma Outlook – Facing an Uncertain Future

Xconomy on Demand

We offer a number of ways to subscribe for free!